Evidence map›Paper›PMID 34594777›Full record

ArticleChina CDC weekly2020

The Effects of Diabetes and Hypertension on the Severity of COVID-19 - Yichang, Hubei Province, 2020.

Yuchang Zhou, Jiajuan Yang, Chengzhong Xu, Chi Hu, Fangfang Lu, Fuzhong Xue, Pei Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in China CDC weekly, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuchang ZhouDepartment of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Jiajuan YangYichang Center for Disease Control and Prevention, Yichang, Hubei, China.
Chengzhong XuYichang Center for Disease Control and Prevention, Yichang, Hubei, China.
Chi HuYichang Center for Disease Control and Prevention, Yichang, Hubei, China.
Fangfang LuYichang Center for Disease Control and Prevention, Yichang, Hubei, China.
Fuzhong XueDepartment of Biostatistics, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
Pei ZhangYichang Center for Disease Control and Prevention, Yichang, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 has become a serious public health issue. A higher proportion of severe patients were senior patients with underlying diseases such as diabetes and hypertension and had a lack of statistical evidence so far. When severe illness was compared with non-severe illness, senior patients were at a greater risk (4.71) than young and middle-aged patients, as well as the odds ratio was about 2.99 patients with diabetes compared to patients without diabetes and hypertension. COVID-19-infectious senior patients with diabetes were inclined to suffer severe illness. Much more attention should be provided for the elderly and individuals with diabetes, for which a community-based education and surveillance program could be considered.

Identifiers

PMID34594777
PMCPMC8393137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.